Mulmit

Rein Therapeutics, Inc.Rein Therapeutics, Inc.

RNTX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-50,631,000-49,900,000-1.96
2024-12-310-65,112,000-62,900,000-3.51
2023-12-310-16,276,000-15,700,000-3.42
2022-12-310-27,647,000-27,329,000-6.02
2021-12-310-26,605,000-26,164,000-5.89

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-05-27VON RICKENBACH JOSEF H4,500
2026-05-26VON RICKENBACH JOSEF H23,190
2026-05-22VON RICKENBACH JOSEF H15,950
2026-05-21VON RICKENBACH JOSEF H3,420
2026-05-08WINDSOR JAMES BRIANSee Remarks150,000
2026-04-30WINDSOR JAMES BRIANSee Remarks25,000
2025-11-14Voss Capital, LP104,183
2025-10-28Voss Capital, LP178,392
2025-10-27Voss Capital, LP92,642
2025-10-27Voss Capital, LP4,840
2025-10-24Voss Capital, LP30,176
2025-07-23Aivado Manuel17,500

8-K events

FiledItems
2026-09-04Regulation FD disclosure · Financial statements and exhibits
2026-08-27Delisting or listing-standard notice
2026-07-21Submission of matters to a vote
2026-05-04Entry into a material agreement · Other events · Financial statements and exhibits
2026-03-02Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits
2026-02-19Officer or director change
2026-01-16Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits
2025-12-11Termination of a material agreement
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…